Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma

Hu,Xudong; Zhang,Zhiqiang; Liang,Zhaofeng; Xie,Dongdong; Zhang,Tao; Yu,Dexin; Zhong,Caiyun

doi:10.3892/ol.2016.5459

Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma

Authors:
- Xudong Hu
- Zhiqiang Zhang
- Zhaofeng Liang
- Dongdong Xie
- Tao Zhang
- Dexin Yu
- Caiyun Zhong
View Affiliations

Affiliations: Department of Urology, Anqing First People's Hospital, Anqing, Anhui 246000, P.R. China, Department of Urology, The Second Hospital of Anhui Medical University, Hefei, Anhui 230032, P.R. China, Department of Nutrition and Food Safety, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, P.R. China
Published online on: December 5, 2016 https://doi.org/10.3892/ol.2016.5459
Pages: 686-694
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Feline sarcoma-related protein (Fer) is a nuclear and cytoplasmic non-receptor protein tyrosine kinase and Fer overexpression is associated with various biological processes. However, the clinicopathological characteristics and molecular mechanisms of Fer expression in bladder urothelial cell carcinoma (UCC) have yet to be elucidated. The present study demonstrated that Fer was significantly upregulated in bladder UCC tissues and cell lines. A clinicopathological analysis suggested that Fer expression was significantly associated with tumor stage, histological grade and lymph node status, and Fer expression was a prognostic factor for overall survival in a multivariate analysis. Furthermore, small interfering RNA (siRNA) was used to silence the expression of the Fer gene in human bladder UCC T24 cells, and was shown to significantly reduce the migration and invasion of the cells. It was also observed that Fer‑siRNA caused the T24 cells to acquire an epithelial cobblestone phenotype, and was able to reverse the epithelial‑mesenchymal transition of the cells. Subsequently, Fer‑knockdown was shown to deactivate the extracellular signal‑regulated kinase/activator protein‑1 signaling pathway in T24 cells. These results indicated, for the first time, that Fer has a critical role in bladder UCC progression and may be a potential therapeutic target for bladder UCC metastasis.

View Figures

View References

1	Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D and Huang Y: microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J. 278:786–792. 2011. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
3	Ben-Dor I, Bern O, Tennenbaum T and Nir U: Cell cycle-dependent nuclear accumulation of the p94fer tyrosine kinase is regulated by its NH2 terminus and is affected by kinase domain integrity and ATP binding. Cell Growth Differ. 10:113–129. 1999.PubMed/NCBI
4	Miyata Y, Kanda S, Sakai H and Greer PA: Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma. Cancer Sci. 104:681–686. 2013. View Article : Google Scholar : PubMed/NCBI
5	Li H, Ren Z, Kang X, Zhang L, Li X, Wang Y, Xue T, Shen Y and Liu Y: Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells. BMC Cancer. 9:3662009. View Article : Google Scholar : PubMed/NCBI
6	Zoubeidi A, Rocha J, Zouanat FZ, Hamel L, Scarlata E, Aprikian AG and Chevalier S: The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth. Mol Cancer Res. 7:142–155. 2009. View Article : Google Scholar : PubMed/NCBI
7	Albeck JG and Brugge JS: Uncovering a tumor suppressor for triple-negative breast cancers. Cell. 144:638–640. 2011. View Article : Google Scholar : PubMed/NCBI
8	Allard P, Zoubeidi A, Nguyen LT, Tessier S, Tanguay S, Chevrette M, Aprikian A and Chevalier S: Links between Fer tyrosine kinase expression levels and prostate cell proliferation. Mol Cell Endocrinol. 159:63–77. 2000. View Article : Google Scholar : PubMed/NCBI
9	Stetler-Stevenson WG and Yu AE: Proteases in invasion: Matrix metalloproteinases. Semin Cancer Biol. 11:143–152. 2001. View Article : Google Scholar : PubMed/NCBI
10	Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
11	Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J and De Herreros A García: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2:84–99. 2000. View Article : Google Scholar : PubMed/NCBI
12	Bolós V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M and Cano A: The transcription factor slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell Sci. 116:499–511. 2003. View Article : Google Scholar : PubMed/NCBI
13	Singh A and Settleman J: EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
14	Sebolt-Leopold JS and Herrera R: Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer. 4:937–947. 2004. View Article : Google Scholar : PubMed/NCBI
15	Angel P and Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1072:129–157. 1991.PubMed/NCBI
16	Raman M, Chen W and Cobb MH: Differential regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007. View Article : Google Scholar : PubMed/NCBI
17	Sobin DH and Wittekind C: TNM Classification of Malignant Tumors. 6th. Wiley-Liss; New York, NY: 2003, View Article : Google Scholar
18	Miyamoto H, Miller JS, Fajardo DA, Lee TK, Netto GJ and Epstein JI: Non-invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system. Pathol Int. 60:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Groblewska M, Siewko M, Mroczko B and Szmitkowski M: The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer. Folia Histochem Cytobiol. 50:12–19. 2012. View Article : Google Scholar : PubMed/NCBI
21	Hao QL, Heisterkamp N and Groffen J: Isolation and sequence analysis of a novel human tyrosine kinase gene. Mol Cell Biol. 9:1587–1593. 1989. View Article : Google Scholar : PubMed/NCBI
22	Orlovsky K, Theodor L, Malovani H, Chowers Y and Nir U: Gamma interferon down-regulates Fer and induces its association with inactive Stat3 in colon carcinoma cells. Oncogene. 21:4997–5001. 2002. View Article : Google Scholar : PubMed/NCBI
23	Ahn J, Truesdell P, Meens J, Kadish C, Yang X, Boag AH and Craig AW: Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis. Mol Cancer Res. 11:952–963. 2013. View Article : Google Scholar : PubMed/NCBI
24	Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
25	Moss LA Shuman, Jensen-Taubman S and Stetler-Stevenson WG: Matrix metalloproteinases: Changing roles in tumor progression and metastasis. Am J Pathol. 181:1895–1899. 2012. View Article : Google Scholar : PubMed/NCBI
26	Scheel C, Onder T, Karnoub A and Weinberg RA: Adaptation versus selection: The origins of metastatic behavior. Cancer Res. 67:11476–11479; discussion 11479–11480. 2007. View Article : Google Scholar : PubMed/NCBI
27	Yang J and Weinberg RA: Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
28	Craig AW and Greer PA: Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells. Mol Cell Biol. 22:6363–6374. 2002. View Article : Google Scholar : PubMed/NCBI
29	Kogata N, Masuda M, Kamioka Y, Yamagishi A, Endo A, Okada M and Mochizuki N: Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells. Mol Biol Cell. 14:3553–3564. 2003. View Article : Google Scholar : PubMed/NCBI
30	Piedra J, Miravet S, Castaño J, Pálmer HG, Heisterkamp N, de Herreros A García and Duñach M: p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin interaction. Mol Cell Biol. 23:2287–2297. 2003. View Article : Google Scholar : PubMed/NCBI
31	Senis YA, Sangrar W, Zirngibl RA, Craig AW, Lee DH and Greer PA: Fps/Fes and Fer non-receptor protein-tyrosine kinases regulate collagen- and ADP-induced platelet aggregation. J Thromb Haemost. 1:1062–1070. 2003. View Article : Google Scholar : PubMed/NCBI
32	Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
33	Liu AN, Zhu ZH, Chang SJ and Hang XS: Twist expression associated with the epithelial-mesenchymal transition in gastric cancer. Mol Cell Biochem. 367:195–203. 2012. View Article : Google Scholar : PubMed/NCBI